Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antistax in chronic venous insufficiency (12-week randomized double-blind placebo-controlled trial)
2008-003932-40Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in venous stasis comparing Antistax 720 mg/day with Placebo (2 arms). Primary endpoint: Change from baseline in limb volume at day 84. Started Jan 2009; status: completed.
02
Drugs
grape seed extract
03
Conditions
venous stasis
Beyond the preview
Go deeper on 2008-003932-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003932-40.